Weil has been recognized for leading BPEA EQT’s sale of HCP Packaging to Carlyle, which has been named a 2022 Cross-Border Deal of the Year by China Business Law Journal.

Weil acted as counsel to BPEA EQT in the sale of 100% of China headquartered HCP, a global leader in the design, development and manufacture of cosmetics packaging, to global investment firm Carlyle (NASDAQ: CG). This landmark transaction was the largest secondary buyout in China and the fourth largest in Asia in 2022, according to Mergermarket.

HCP is one of the world’s largest beauty packaging providers (#1 in Asia, #2 globally) with production and manufacturing facilities across China, the United States, Mexico and Europe. It works with over 250 leading cosmetics, skincare and fragrance brands including Estée Lauder, L’Oreal, Shiseido and many others on innovative and sustainable packaging solutions.

The Weil team was led by Hong Kong Private Equity partners Chris Welty and Sandy Lin, with support from the Firm’s Banking and Finance team in Hong Kong, as well as the Firm’s multi-disciplinary specialists in France, Germany, the United Kingdom and the United States.

The global Weil team included Jie Yuan, Graham Price, Hongzhen Huang, Jacky Sin, Max Chu, Connie Ng and Isolde Tsukabayashi in Hong Kong; Emmanuelle Henry and Lise Laplaud in Paris; Manuel-Peter Fringer and Andreas Fogel in Munich; Thomas Weatherill in London; Michael Epstein, Paul Wessel, Nathan Cunningham, Meggin Bednarczyk, Catherine Kim, Ace Szmolyan in New York; Shawn Cooley, Annemargaret Connolly and Matthew D. Morton in Washington, D.C.; and Leslie Smith in Dallas.

The China Business Law Journal Deal of the Year Awards selected winning transactions that stood out based on their overall significance, complexity and innovation.